Chronic intestinal inflammation and seronegative spondyloarthropathy in children

Digestive and Liver Disease

Volumn 37, Issue 10, 2005, Pages 761-767

  Conti, F ^a   Borrelli, O ^a   Anania, C ^a   Marocchi, E ^a   Romeo, E F ^a   Paganelli, M ^a   Valesini, G ^a   Cucchiara, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Inflammatory bowel disease; Lymphoid nodular hyperplasia (LNH); Paediatrics; Spondyloarthropathy

Indexed keywords

AZATHIOPRINE; HLA B27 ANTIGEN; INFLIXIMAB; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; SALAZOSULFAPYRIDINE; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; GASTROINTESTINAL AGENT;

ADOLESCENT; ANTIGEN DETECTION; ARTHROPATHY; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COLITIS; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; ENTERITIS; FEMALE; GASTROINTESTINAL BIOPSY; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JOINT RADIOGRAPHY; LYMPH NODE HYPERPLASIA; MAINTENANCE THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PHENOTYPE; SACROILIAC JOINT; SERODIAGNOSIS; SPONDYLOARTHROPATHY; ULCERATIVE COLITIS; BLOOD; COMPARATIVE STUDY; EPIDEMIOLOGY; GASTROINTESTINAL ENDOSCOPY; IMMUNOLOGY; INTESTINE MUCOSA; PATHOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL AGENTS; HLA-B27 ANTIGEN; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; SEROEPIDEMIOLOGIC STUDIES; SPONDYLARTHROPATHIES; TREATMENT OUTCOME;

EID: 33744773553     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.04.028     Document Type: Article

References (34)

1. Khan M.A. Updates on spondyloarthropathies. Ann Intern Med 136 (2002) 896-907
2. François R.J., Braun J., and Khan M.A. Entheses and enthesitis: a histopathologic review and relevance to spondyloarthropathies. Curr Opin Rheumatol 13 (2001) 255-264
3. Baeten D., De Keyser F., Mielants H., and Veys E.M. Immune linkages between inflammatory bowel disease and spondyloarthropathies. Curr Opin Rheumatol 14 (2002) 242-247
4. Baeten D., de Keyser F., Mielants H., and Veys E.M. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 16 (2002) 537-549
5. Palm O., Moum B., Ongre A., and Gran J.T. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 29 (2002) 511-515
6. Grand R.J., Ramakrishna J., and Calenda K.A. Inflammatory bowel disease in the pediatric patient. Gastroenterol Clin North Am 24 (1995) 613-632
7. Mamula P., Markowitz J.E., and Baldassano R.N. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 32 (2003) 967-995
8. De Keyser F., Baeten D., Van den Bosch F., De Vos M., Cuvelier C., Mielants H., et al. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep 4 (2002) 525-532
9. De Keyser F., Elewaut D., De Vos M., De Vlam K., Cuvelier C., Mielants H., et al. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am 24 (1998) 785-813
10. Mielants H., Veys E.M., De Vos M., Cuvelier C., Goemaere S., De Clercq L., et al. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 22 (1995) 2266-2272
11. Tse S.M., and Laxer R.M. Juvenile spondyloarthropathy. Curr Opin Rheumatol 15 (2003) 374-379
12. Picco P., Gattorno M., Marchese N., Vignola S., Sormani M.P., Barabino A., et al. Increased gut permeability in juvenile chronic arthritis. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 18 (2000) 773-778
13. Geboes K., and De Hertogh G. Indeterminate colitis. Inflamm Bowel Dis 9 (2003) 324-331
14. Ritchie D.M., Boyle J.A., McInnes J.M., Jasani M.K., Dalakos T.G., Grieveson P., et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37 (1968) 393-406
15. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34 (1991) 1218-1227
16. Collantes E., Veroz R., Escudero A., Munoz E., Munoz M.C., Cisnal A., et al. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Joint Bone Spine 67 (2000) 516-520
17. Brandt J., Bollow M., Haberle J., Rudwaleit M., Eggens U., Distler A., et al. Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy. Rheumatology 38 (1999) 831-836
18. Escher J.C., Taminiau J.A., Nieuwenhuis E.E., Buller H.A., and Grand R.J. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm Bowel Dis 9 (2003) 34-58
19. De Keyser F., Baeten D., Van den Bosch F., Kruithof E., Mielants H., and Veys E.M. Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation. Rheum Dis Clin North Am 29 (2003) 463-479
20. Orchard T.R., Wordsworth B.P., and Jewell D.P. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42 (1998) 387-391
21. Mielants H., Veys E.M., Cuvelier C., De Vos M., Goemaere S., De Clercq L., et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 22 (1995) 2273-2278
22. Demetter P., Van Huysse J.A., De Keyser F., Van Damme N., Verbruggen G., Mielants H., et al. Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis. J Pathol 198 (2002) 517-522
23. Kokkonen J., and Karttunen T.J. Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: an indication of enhanced immune response?. J Pediatr Gastroenterol Nutr 34 (2002) 42-46
24. Prieur A.M., Listrat V., and Dougados M. Evaluation of the ESSG and the Amor criteria for juvenile spondyloarthropathies (JSA): study of 310 consecutive children referred to one pediatric rheumatology center. Arhtritis Rheum 33 (1990) D195
25. Prieur A.M., Listrat V., Dougados M., and Amor B. Criteria for classification of spondyloarthropathies in children. Arch Fr Pediatr 50 (1993) 379-385
26. Barkham N., Marzo-Ortega H., McGonagle D., and Emery P. How to diagnose axial spondyloarthropathy early. Ann Rheum Dis 63 (2004) 471-472
27. Williamson L., Dockerty L., Dalbeth N., McNally E., Ostlere S., and Wordsworth B.P. Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology 43 (2004) 85-88
28. De Vos M., Mielants H., Cuvelier C., Elewaut A., and Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 110 (1996) 1696-1703
29. Demetter P., De Vos M., Van Damme N., Baeten D., Elewaut D., Vermeulen S., et al. Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. Am J Clin Pathol 114 (2000) 364-370
30. Demetter P., Baeten D., De Keyser F., De Vos M., Van Damme N., Verbruggen G., et al. Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex. Ann Rheum Dis 59 (2000) 211-216
31. Van Damme N., Elewaut D., Baeten D., Demetter P., Cuvelier C., Verbruggen G., et al. Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin. Clin Exp Rheumatol 19 (2001) 681-687
32. Van Damme N., De Vos M., Baeten D., Demetter P., Mielants H., Verbruggen G., et al. Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy. Ann Rheum Dis 60 (2001) 459-495
33. Salmi M., and Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol 166 (2001) 4650-4657
34. May E., Marker-Hermann E., Wittig B.M., Zeitz M., Meyer zum Buschenfelde K.H., and Duchmann R. Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology 119 (2000) 1745-1755